Advertisement

Pharmacy Report

Pfizer to make Gilead's remdesivir | 32 pharmacies ranked by customer satisfaction | Gates Foundation to make low-cost COVID-19 vaccine | A 2020 timeline of CVS business moves

August 10, 2020 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. Pfizer inks deal with Gilead to manufacture remdevisir for COVID-19 patients Full story 2. Gates Foundation, world's largest vaccine maker to make low-cost COVID-19 vaccine Full story 3.…

Trump to order US to buy certain drugs domestically | Moderna to charge up to $37 for COVID-19 vaccine, CEO says | Mallinckrodt considers bankruptcy | Globe: Brigham president sold Moderna stock before board resignation

August 6, 2020 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. Trump order to require US to buy certain drugs only from US factories Full story 2. Moderna will charge $32 to $37 for COVID-19 vaccine, CEO says Full…

CVS profit climbs $1B year-over-year | J&J, US ink deal for 100M COVID-19 vaccine doses | Novavax reports positive COVID-19 vaccine data | 3 retail pharma giants disclose data breaches

August 5, 2020 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. Novavax reports positive COVID-19 vaccine data Full story 2. J&J signs $1B+ deal with the US for 100 million COVID-19 vaccine doses Full story 3. CVS reports strong…

Henry Ford defends study, slams politicization of hydroxychloroquine | Sanofi, GSK under investigation for Zantac | 10 best, worst states for healthcare | Amazon's PillPack partners with Horizon, Prime Therapeutics

August 4, 2020 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. Henry Ford researchers defend hydroxychloroquine study, slam politics surrounding drug Full story 2. Sanofi, GlaxoSmithKline under investigation for possible carcinogen in Zantac Full story 3. Amazon's PillPack partners…

Ohio reverses hydroxychloroquine ban | 10 most expensive Part B drugs | Appeals court: 340B payment cuts are legal | Sanofi, GSK get up to $2.1B from US for COVID-19 vaccine | Chinese hackers allegedly targeted Moderna's COVID-19 research

August 3, 2020 BHR Newsletter Virtual Events  •  Webinars   •   Recent Whitepapers   •   Podcasts 1. Ohio pharmacy board reverses hydroxychloroquine ban Full story 2. Moderna's coronavirus vaccine research alleged target of Chinese hackers Full story 3. US to pay Sanofi, GlaxoSmithKline up to $2.1B…

Advertisement

Ohio first state to ban hydroxychloroquine for COVID-19 | US to send Texas 500 cases of remdesivir | Hospitals to spend 3.29% more on drugs in 2021 | Operation Warp Speed: A timeline

July 30, 2020 BHR Newsletter Virtual Events  •  Webinars   •   Recent Whitepapers   •   Podcasts 1. Ohio's board of pharmacy bans hydroxychloroquine for use in COVID-19 patients Full story 2. Hospitals will spend 3.29% more on drugs in 2021, Vizient projects Full story 3. US…

Moderna, Pfizer start late-stage COVID-19 vaccine trials | These 20 hospitals top US News' Honor Roll | CVS loses 21K patients' info after vandalism | Drug lobbies don't show for White House meeting

July 28, 2020 BHR Newsletter Virtual Events  •  Webinars   •   Recent Whitepapers   •   Podcasts 1. Moderna, Pfizer begin late-stage COVID-19 vaccine trials Full story 2. CVS Pharmacy loses 21,289 patients' information after vandalism Full story 3. Indivior pleads guilty, agrees to pay $600M to…

Fresenius Kabi recalls sedative | Biogen CFO steps down | 10 drugmakers expected to be most profitable in 5 years | DEA rules leave hospitals short on IV opioids, Premier says

July 23, 2020 BHR Newsletter Virtual Events  •  Webinars   •   Recent Whitepapers   •   Podcasts 1. Fresenius Kabi recalls sedative, cites possible cross-contamination Full story 2. 10 drugmakers expected to make the most money in the next 5 years Full story 3. DEA rules leave…

Advertisement